youtube_live
Q3 2026 earnings • released • EPS beat +8,62% • Revenue beat +2,31%
See resultschevron_right
EW:NYSE
Edwards Lifesciences Corp
100,82 USD
arrow_upward
+1,46%(+1,45) 1D
100,00 USD
arrow_downward
-0,81% (-0,82)bedtimeAfter hours
Closed: 5-ноя., 16:00:05 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
100,67 USD
High
104,16 USD
Low
98,77 USD
Mkt. cap
58,11 млд
Avg. vol.
4,14 млн
Volume
0,00
P/E ratio
58,33
52-wk high
104,16 USD
52-wk low
74,66 USD
EPS
1,73 USD
Beta
0,85
Shares outstanding
576,40 млн
No. of employees
16 миң
Open
100,67 USD
High
104,16 USD
Low
98,77 USD
Mkt. cap
58,11 млд
Avg. vol.
4,14 млн
Volume
0,00
P/E ratio
58,33
52-wk high
104,16 USD
52-wk low
74,66 USD
EPS
1,73 USD
Beta
0,85
Shares outstanding
576,40 млн
No. of employees
16 миң
News stories
From web sources and news partners
Zacks
·
14 саат мурун
ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
Stocktwits
·
14 саат мурун
CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?
GuruFocus
·
15 саат мурун
Edwards Lifesciences Corp (EW) (Q3 2026) Earnings Call Highlight
Investing.com
·
17 саат мурун
Edwards Lifesciences stock rating reiterated at Buy by TD Cowen
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 миң
Founded1958
HeadquartersИрвайн, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
IndustryMedical device
Websiteedwards.com